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 Increasing emergence of antibiotic resistance in bacteria during the past few 
decades became a major public health concern and had reduced the efficacy of the 
conventional therapies on methicillin-resistant Staphylococcus aureus (MRSA) 
and Escherichia coli (E. coli). The objective of current study is to examine the 
effects of atmospheric pressure non-thermal dielectric barrier discharge (DBD) 
plasma on decontamination of MRSA as a common musculoskeletal pathogen and 
E. coli as another cause of bone, joint and soft tissue infections. Treatments were
done in planktonic phase and in colonies on surface of agarose gel and in 
suspension. On agarose gel surface in planktonic phase inoculated plates were 
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treated for 0,30, 60 and 120 sec. results demonstrated complete decontamination 
of E. coli and MRSA cells on agar plates with a bacterial surface density of 1.27 × 
105 CFU/cm2 following 30 sec and 60 sec of plasma treatment respectively. In 
colonies, Plates were plasma treated for 1,2,3,4 and 5 min. Reduction rates of 7 
log10 steps in the number of viable CFUs in E. coli colonies was observed 
following 5 min of plasma treatment. The colony growth was halted and no more 
growth in colony size was observed during a 24 hour monitoring period. For 
MRSA colonies results demonstrated 2 log10 to 7 log10 steps reduction in the 
number of viable CFUs in each colony after 5 minutes of plasma treatment. After 
monitoring the regrowth of plasma treated colonies in fresh media, DBD plasma 
treated colonies showed prolonged lag time during the growth process. In liquid 
phase, results showed complete decontamination of E. coli suspension with the 
concentration of 108 CFU/ml in 1mm deep container following 90 sec of 
treatment. We also demonstrated that 120 sec plasma treated DI water will cause 
2 log 10 steps of reduction in the concentration of the suspension with the initial 
concentration of 109 CFU/ml.  Moreover, pH reduction and nitric oxide diffusion 
in liquid phase were confirmed. Finally, we demonstrated that nitric oxide was an 
effective reactive agent in the decontamination process and diffused into the 
agarose gel radially and in depth as a result of plasma treatment. 
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Chapter one 
Introduction and Background 
1.1. Antibiotic resistance in bacteria 
Antibiotic resistant bacterial species are becoming a new serious thread for society 
health. About 90% of the death cases related to infections are happening because of the 
antibiotic resistance species [1]. Antibiotic resistance infections are happening too 
frequently and the pathogens are emerging resistance to many classes of antibiotics.  The 
emergence of resistance to many antibiotics and the lack of the production of new 
effective antibiotics is an issue that needs immediate attention.  
In order to better clarify the huge dimensions of the problem, it should be noted that these 
antimicrobial resistant infections are currently leading to 50000 deaths each year only in 
US and Europe. High Mortality and morbidity rates for methicillin-resistant 
Staphylococcus aureus (MRSA) in US are causing 19000 deaths and 90000 infections per 
year[2, 3]. Investigations demonstrated that in 15 European countries more than 10% of 
bloodstream Staphylococcus aureus infections are caused by methicillin-resistant strains 
(MRSA), with resistance rates close to 50%[4] in some of these countries.  
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Figure 1-1. Deaths attributable to Antimicrobial Resistance (AMR) every year compared 
to other major causes of death [5]. 
 
According to  Jim O’Neill and his research group [5] the anticipated death rate from 
antimicrobial resistance will be 10 million people per year by 2050 with a cost of  100 
trillion USD (Figure 1-1).  Without proper treatment for the drug resistant bacteria, many 
medical procedure including, organ transplants, chemotherapy, hip replacements, 
hemodialysis and care for preterm infants can be  considered very high risk 
procedures[6]. 
The complex interactions associated with the emergence of antibacterial resistance from 
biological, social, industrial and legislative points of view are summarized in Table 1[7]. 
Based on recent investigations, Bacteria that has already shown a concerning level of 
resistance are Klebsiella pneumonia, Escherichia coli (E. coli), Staphylococcus aureus 
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and Pseudomonas aeruginosa.[5,7] Excess mortality rates are associated with infections 
caused by these drug resistant species and the prolonged hospital stay lengths impose 
considerable costs on health care system[8]. 
 
Table 1. Explaining antimicrobial resistance from different perspectives [7] 
Biological Explanation (contributing factors) 
Selective pressure: Bacteria that are not killed by an antimicrobial continue to survive 
thereby becoming the prevailing type. This results in an imbalance of the ideal microflora 
at a community and individual level. 
Evolution: To ensure survival in the presence of antibiotics, bacteria develop genetic and 
biochemical mechanisms such as alterations within the existing genome and gene transfer 
within and between species. 
Transmission: The transmission of gene sequences encoding for resistance is highly 
efficacious due to the small number of successful clonal lineages that share genetics 
related in pathogenicity and antimicrobial resistance. 
Societal Explanation (contributing factors) 
Overuse: Capacious antibiotic use includes use based on the incorrect medical 
indications, administration route, dose and/or treatment duration. This then creates a 
selective pressure favoring resistant bacteria. 
Transmission: Factors such as poor hygiene, densely populated settings, international 
trade, travelling, ecosystem disturbances and the increase of the ageing and 
immunocompromised populations further promote the propagation of resistant microbes. 
Underuse: An inadequate or adulterated supply of the appropriate antimicrobials to treat 
an individual perpetuates AMR by creating a selective pressure to favor resistant 
bacteria. 
 Hospitals: Antibiotics are often less expensive than AMR prevention strategies. This 
often results in many hospitals preferring to provide treatment rather than implement 
prevention mechanisms. 
Behaviors: Patients may demand antibiotics from their providers thereby resulting in 
inappropriate antibiotic use. Additionally, providers may feel pressured to engage in 
inappropriate antibiotic use thereby further discouraging prudent antibiotic use. 
 Economic: Many healthcare systems are weak and underfunded. Coupled with the rising 
costs of healthcare services, pressure on providers to seek economical alternatives is 
created. Since antibiotics are often inexpensive, providers may feel pressured to 
distribute them as a hasty alternative. Weak surveillance is also an issue since many 
surveillance systems cannot be fully and appropriately developed due to lack of funds. 
Agriculture: More than half of all of the antibiotics consumed within the USA are 
utilized for agriculture. This overuse creates a selective pressure that favors bacteria that 
are resistant to antimicrobials. The capacious overuse affects the surrounding livestock, 
surrounding water and soil and public health. The contribution by this animal “reservoir” 
is not insignificant although nosocomial (i.e. hospital-derived) infections and human-to-
human transfer of bacteria occurs constantly and routinely (sharing meals, aerosolized 
dissemination of bacteria, and intimate physical contact). 
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Industrial Explanation 
Diagnostic tools: Providers may not have the appropriate tools to properly distinguish 
between a viral and bacterial infection that would benefit from treatment and this may 
result in a misdiagnosis and inappropriate antimicrobial use. The development of 
diagnostic tools to distinguish between viral and bacterial infections is critical to 
appropriately treat the patient while reducing the misuse of antibiotics. Access to existing 
tools is also required as it is lacking in many low- and middle-income countries. 
Pharmaceutical industries: The R & D for antibiotics often lacks the financial incentives 
that many pharmaceutical companies seek. This results in a lack of innovative 
antimicrobial therapies against AMR. Further, antimicrobial residues from 
pharmaceutical industries and hospitals are contaminating water supplies in many parts 
of the world. 
Pipeline: Between 1930 and 1962, more than 20 new classes of antibiotics were 
developed. Between then and 2011, only two new classes of antibiotics have been 
marketed for human use. A dearth of new antibiotics results in inability to treat emerging 
resistance to existing antibiotics, but resistance is an inevitable process. 
Legislative Explanation 
Registration: There have been several antibiotic registration difficulties. These 
difficulties may present additional costs, time and other resources that may discourage 
the company to continue the process. These registration difficulties may discourage other 
companies from entering the antibiotic development pipeline. 
Requirements: The FDA has implemented stricter requirements, such as decreased non-
inferiority margins. This results in increased costs and clinical trial time which further 
discourage the development of antibiotics. 
 Legislation against over the counter (OTC) sale is absent or not enforced in many 
countries. 
 
Considering all the above facts there is a serious need to boost the production of new 
antibacterial drugs and to focus on creation of novel techniques to control these 
pathogenic bacteria. In this study, the efficacy of floating atmospheric pressure dielectric 
barrier discharge system in ambient air (DBD plasma) as a novel technique for bacterial 
decontamination of methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia 
coli (E. coli) as two most common bacteria causing antibiotic resistant infections was 
investigated. 
Staphylococcus aureus (S. aureus) is one of the common musculoskeletal pathogens. This 
bacterium is commonly living on the skin and mucous membranes of human. About 15-
40 percent of healthy people have these bacteria on their skin without any active 
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infections[9]. It is one of the most common pathogens sought in clinical microbiology 
laboratories, which frequently causes wound infections[10]. It is a gram-positive coccal 
bacterium, which is an important cause of nosocomial infections. To diagnose a S. aureus 
infections, wound swabs are cultured usually onto  nonspecific media and suspect 
colonies are confirmed by biochemical tests [11, 12]. Escherichia coli (E. coli) is a 
bacteria usually living in the intestine of healthy people or animals. It is a gram negative 
bacterium that can make infections in human usually when and individual consumes a 
food that is contaminated specially ground beef and milk. This pathogen can also be a 
serious cause for skin and soft tissue infections [13], [10]. 
1.2. Plasma  
Plasma, the forth state of matter, is a cocktail of electrons, uncharged gas molecules, 
atoms, free radicals, ions, and UV photons [14]. Plasma exists in nature in different forms 
containing lightning and solar corona and can artificially be generated using different 
energy sources including laser, heat, electrical current, or a strong electromagnetic 
field[15]. Plasma can be generated as thermal and non-thermal. Both thermal and non-
thermal plasma exist in nature as lightning and aurora borealis (northern lights) 
respectively. Synthetic plasma is being used in plasma TV’s, lighting, welding and many 
other occasions and can be employed in medicine.  Earlier, mostly thermal plasma has 
been used in medicine during surgical procedures. Electrocautery is used to remove 
unwanted or harmful tissue [16, 17]. Argon Thermal Plasma Coagulators also widely 
used to rapidly coagulate blood[18]. However these techniques can lead to serious tissue 
damage therefore non-thermal plasma is being more and more used and its advantage is 
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to eliminate the thermal damage and to react with the tissue mostly through biochemical 
reactions[19, 20].  
Within the past decade the antimicrobial effects of non-thermal plasma were revealed. 
UV light generation often utilizes lower pressure plasma discharges and ozone is also 
typically produced by non-thermal plasma to be used as a disinfectant for water. 
However, a wide range of applications for non-thermal atmospheric pressure plasma in 
medicine has been discovered in recent years including the utilization of plasma for the 
purpose of enhancing wound healing, killing pathogens on wounds, burns, within 
intestines and teeth, blood coagulation without damage of surrounding tissue,  treatment 
of cancer cells and progenitor differentiation [21-24]. Non-thermal plasma has been also 
used for clinical purposes such as sterilization of the surface [25] and modifying the 
surface to improve cell attachment[26-28].  
 
1.3. Bacterial Inactivation by Non-Thermal Plasma 
Sterilization is a term that is used when a device or surface is free from any form of living 
microorganisms including bacteria, virus and spores[29]. Disinfection on the other 
hand, is a procedure that will eliminates recognized pathogenic microorganisms but not 
necessarily all the forms of microbes including bacterial spores. The efficacy of 
disinfection is dependent on the time of treatment and the kinds of microorganisms and 
also the concentration or amount of the pathogens. When a liquid antimicrobial chemical 
in applied on skin or living tissue whether for swabbing an injection site or for hand 
washing to destroy microorganisms, the term antisepsis is usually used. In current study 
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we use the non-thermal plasma potential to be utilized for disinfection in general, ranging 
from complete sterilization to partial decontamination or for producing liquids that have 
antiseptic property. Various non-thermal plasma systems has be developed for 
biomedical applications including corona discharge, microwave (MW) discharges, 
plasma jet, gliding arc and dielectric barrier discharge (DBD)[30-33]. 
Mounir Laroussi and his group published one of the very first papers about the utilization 
of non-thermal plasma for complete sterilization of bacteria. The treatment was applied 
on Pseudomonas fluorescens for 10, 15 and 20 min and for all the treatment times they 
reported complete sterilization of the bacteria[34]. Since then, studies are implemented 
on this topic with the purpose of finding the answers for many unknowns about the 
antimicrobial effects of non-thermal plasma. Non-thermal plasma can be utilized in food 
industry, water treatments and for medical and clinical applications on human tissue. 
Some of the most important subjects that are being investigated are the physical and 
biochemical phenomena observed during plasma treatment by which non-thermal plasma 
destroys the pathogens. The minimum time and power (dosage) needed for complete 
sterilization and what kind of plasma system to use for each specific application are other 
important topics.    
A comprehensive review on sterilization using non-thermal plasma published by Moisan 
et al. [35] discussed the most important mechanisms involved in the plasma-assisted 
inactivation of. The review compared the DBD and MW discharges using air, argon, 
oxygen, CO2 and the mixtures of oxygen/nitrogen and argon/ oxygen as the working 
gases. The effect of these plasma treatments on Escherichia coli, Staphylococcus aureus 
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and Bacillus subtilis spores were discussed. They suggest that the main mechanisms of 
disinfection are DNA destruction by UV irradiation and the erosion of the microorganism 
through photo desorption and etching and report the dependency of the antimicrobial 
efficacy on the thickness of the samples as the most importing shortcoming of this 
technique. 
The utilization of non-thermal plasma for disinfection continued to spread into many 
fields. Leipold et al.[36] used a rotating meat cutting tool in which the knife served as a 
ground electrode. They reported a log 5 reduction of L. innocua, after 340 s of plasma 
operation.  
Boudam et al. [37] claimed that it is possible to achieve the same level of 
decontamination by UV photons that is possible under the sole action of reactive species. 
Many investigations were done on this issue trying to define exactly how much each 
antimicrobial agent existing in plasma is participating in the decontamination process. 
Further, studies claimed that the effect of UV photons is minor compare to the effect of 
reactive species in the bacterial inactivation associate with non-thermal plasma treatment. 
Dobrynin et al. [38] has made an attempt to thoroughly investigate the mechanisms of 
plasma interaction with living tissues and cells and to study the effect of each of the 
antimicrobial agents existent in plasma on the interaction. They proposed a general 
scheme of interaction of direct non-thermal discharges with biological systems (Figure 1-
2). They also offered a hypothesis on the selective effect on plasma treatment which 
means plasma with interacts differently with various kinds of microorganisms and cells 
including bacteria (prokaryotes) and mammalian cells (eukaryotes). They explain that 
bacterial cells are much smaller and have a higher surface to volume ratio and they 
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usually act as a single cell while mammalian cells that are higher order cells had 
developed more resistance to external stress and usually communicate and this will lower 
the effect of the poison. Also their metabolism of ROS is different. Human cells have 
protection from some species such as O-2 but bacteria either have lower resistance or 
lack it completely. 
 
 
 
 
Figure 1-2. Summary of key findings on plasma interaction with biological organisms. 
[35] 
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 As research on possible antimicrobial properties of non-thermal plasma rapidly 
continued, Ehlbeck et al. [33] published a review on the topic that and studied a wide 
range of bacterial species and different non-thermal plasma systems. The purpose of this 
work was to verify the efficacy of non-thermal plasma in decontamination of 
microorganisms.  
Dobrynin et al. [39] reported further research results on inactivation of the bacteria using 
corona discharge. They investigate the role of various reactive species in the bacterial 
inactivation process using O2, N2, Ar and He gases. They demonstrated that the best 
results are happening in O2-H2O mixture and no sterilization in happening in pure N2, 
pure O2 and an N2–H2O mixture. They then concluded that main effect of charged 
particles in the inactivation process may be the related to faster transport of active 
peroxide species—cluster ions OH−(H2O)n and H3O+(H2O)n. They declare that the 
efficiency of these radicals is much higher than the efficiency of the nitrogen and argon 
ions and oxygen radicals and ions (including O2
-, O4
+ and O3). 
More research has been conducted on the function of reactive nitrogen and oxygen 
species associate with non-thermal plasma treatment. Graves et al. [40] had gathered a 
review paper to emphasize on the critical role of these reactive species in biology. They 
imply that although these species can be involved in inducing negative effects on human 
as in aging procedure, they can be used as very effective therapeutic agents. They believe 
that the most critical challenge in application of the non-thermal plasma produced 
reactive species for therapeutic benefits is to be able to minimize the side effects that 
associated with them. As they report, non-thermal plasma is capable of being a very 
effective treatment mimicking the innate immune response to infection caused by 
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antibiotic-resistant bacterial species without inducing any further resistant development. 
This very important issue has been further investigated by many researchers and 
surprisingly they state that the real mechanism by which antibiotics kill bacteria is not 
what was accepted for many years as they say” If asked to think about how an antibiotic 
works, you will probably envisage the drug entering the bacterium, inhibiting an 
important biochemical function, such as protein, RNA, DNA or cell wall synthesis, and 
then the microbe dying. However, this is incorrect”[41]. As they explain enzyme 
inhibitors has been found, but no new antibacterial drug. Exploring the mechanisms by 
which antibiotics cause cell death is a broad research area with is beyond the scope of this 
work but it is evident that there is need for new antibacterial drugs and there are solid 
biological reasons that reactive oxygen and nitrogen species play an important role in the 
human body immune system and are good candidates to be used for antibacterial 
purposes. 
Previously, a non-thermal uniform DBD plasma system that had the potential to be 
applied on non-uniform surfaces, e.g. living tissue, had been developed and investigated 
on by Dr. Halim Ayan. Based on his previous works, atmospheric pressure non-thermal 
dielectric barrier discharge (DBD) plasma had been used in this study, which is a novel 
system in medicine.  This system generates non-thermal plasma between the high voltage 
electrode that is insulated and covered with a quartz surface and a second electrode that is 
grounded electrode or the surface of the biological sample. The use of dielectric barrier 
causes plasma is non-thermal and compared to thermal plasma that induces thermal 
damage to the tissue it is safe to use on human tissue. The plasma discharge will be 
ignited when the distance between two electrodes is less than about 3 mm. In this system 
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air is used as the working gas. This serves as a huge advantage and makes the system less 
complex compare to other DBD plasmas that can be generated either in special gas flow 
or vacuum [19]. Atmospheric pressure non-thermal (DBD) plasma generates many 
species that are physically and chemically active and react with the biological samples 
when applied [35]. Cells or the tissue surface that is plasma treated will be exposed to 
short and long living reactive species, neutral atoms and molecules, including ozone 
(O3), nitric oxide (NO), Hydroxyl (OH) radicals, and singlet oxygen. There will also 
exist a significant flux of charged particles, including both electrons and positive and 
negative ions like super oxide radicals [42]. 
1.4. Objectives and Outlines of the Thesis 
Emergence of antibiotic-resistant bacteria is an increasing concern in wound infections. 
These organisms colonize wounds, often necessitating aggressive wound management 
with a very limited choice of antibiotics. Staphylococcus aureus is one of the common 
musculoskeletal pathogens causing Osteomyelitis; a bone, cartilage, and surrounding 
tissue infection as a result of injury (bone lesions) or surgery [43-45].  E coli is also one 
of the strains that can cause bone, joint and soft tissue infection[10]. Several conventional 
techniques are used for the prevention and management of wound infection. It is 
nonetheless a gold standard to treat patients with deep wounds with antibiotic prophylaxis 
to prevent bacteria from being released into the blood stream and cause infection 
complications. This procedure is combined with debridement and surgical processes. 
Washing wounds with antibiotic solutions or use of topical antibiotics are rare[46]. In 
some cases, silver and other noble metals are potential allies in fighting pathogens in 
wounds [47]. Considering that antibiotics do not reach the source of the wound infection 
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but only the area around the wound and also the emerging resistance of bacteria to 
antibiotics these methods are not very efficient in the treatment of antibiotic resistant 
species. 
Antibiotic resistance in S. aureus is a serious problem; thus, there is considerable need for 
an efficient and nondestructive way to decontaminate wounds and prevent germs from 
spreading fuels the search for other possible methods and research currently underway 
aims at developing new techniques for decontamination of antibiotic resistant 
species[48].  
The application of atmospheric pressure non-thermal dielectric barrier discharge (DBD) 
plasma is a new and effective method in the decontamination of living tissue. [27] In this 
study, DBD plasma is used, which is of particular interest for biomedical use. Several 
studies suggest that reactive species produced in plasma, like nitric oxide and hydroxyl 
radicals, have antimicrobial effects and can be useful in the decontamination of human 
tissue[49-52].The application of DBD plasma on human tissue is particularly promising 
due to its low temperature, the simple setup and treatment and the typically low electric 
current[53]. In addition, utilizing air as the working gas in atmospheric pressure provides 
huge advantage over other plasma systems in which gas delivery systems should be 
utilized. DBD plasma treatment is a contact free and painless procedure, causing no harm 
to the tissue while killing many known pathogens and also promoting wound healing[54]. 
The aim of this work is to study the in vitro bactericidal efficacy of DBD plasma 
treatment on methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli 
(E. coli) in different media. To compare the efficacy of plasma treatment on bacteria in 
13
  
planktonic phase and in colonies, bacteria were grown in vitro as planktonic cultures and 
in colonies as a common form of bacterial cell aggregation on agarose gel. Dosage 
dependency of the plasma treatment was also investigated. The emergence of secondary 
resistance of bacterial cells to plasma treatment was tested. Bacterial cells were also 
plasma treated in suspension and the bactericidal efficacy of plasma treated DI water on 
bacterial cells was studied. In this work it was also tried to detect some of the most 
important reactive species that are generated during DBD plasma treatment and are 
important factors in the decontamination process by means of optical spectroscopy 
devices, griess assay and measurement of pH change after DBD plasma treatment. 
Scanning Electron Microscopy (SEM) pictures were also taken to further investigate the 
change in morphology of the bacterial cells by plasma treatment. 
In chapter 2, the utilized DBD plasma setup is explained. In chapter 3, efficacy of plasma 
treatment on bacteria in planktonic phase and in colonies on agarose gel was studied.  
Chapter 4, bacterial cells were plasma treated in suspension and the also bactericidal 
efficacy of plasma treated DI water on bacterial cells was studied.  In each chapter the 
experimental set-ups along with the materials and methods are explained. All the samples 
were run in minimum triplicates. The results are then presented and discussed. Several 
procedures had been carried out to investigate bactericidal efficacy of the DBD plasma 
and the interaction of plasma treatment and plasma treated targets. Finally, the last 
chapter is dedicated to a summary and discussion of the conclusions which can be drawn 
from this thesis. 
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Chapter two 
Experimental Dielectric Barrier Discharge (DBD) Plasma 
Setup 
2.1. Introduction 
The DBD plasma system used in my studies was introduced by Gregory Fridman et al. 
[19] as the Floating-Electrode Dielectric Barrier Discharge plasma (FE-DBD plasma). 
This system was proven to be electrically safe to apply on human subjects. This system 
was used as a main plasma system for decontamination in many studies since then. This 
new DBD plasma system was built based on the plasma system proposed by Siemens in 
19th century[55]. The high voltage in applied continuously or as pulses with short 
durations between two electrodes which were insulated. This system could be utilized 
using various working gases .In case no gas flow is applied and the lower electrode is by 
the treatment target that would have a high water content and high charge storage 
capacity (living tissue or agarose gel); the FE-DBD plasma is created in atmospheric 
ambient air(Figure 2-1).[19]  
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Figure 2-1. Electrically safe non-thermal e-plasma for treatment of living tissue without 
causing damage [19] 
 
The produced plasma will be characterized based on electrical wave form analysis and 
optical emission spectra. Moon et al. [56] had analyzed an atmospheric-pressure, 
uniform, continuous, glow plasma which was produced in ambient air assisted by argon 
feeding gas, using optical emission spectroscopy; to detect the reactive species produced 
in the gaseous phase. A typical emission spectrum of the plasma demonstrates molecular 
OH (~306–310 nm), molecular N2 (330–425 nm) and exited oxygen atoms (777 and 844 
nm) peaks (Figure 2-2). Similar results was reported by A. Meiners et al. [57], Marcel 
Hähnel et al. [58] and Mohammed Yousfi et al. [59]. 
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Figure 2-2. A typical emission spectrum of the plasma. Due to the argon feeding gas, 
argon atomic lines (~696.5, 763.5, 811.4, etc.) are dominant. On the other hand, the OH 
molecular spectrum (~306–310 nm), N2 molecular spectrum9 ~330–425 nm), and 
excited oxygen atom emission lines (~777 and 844 nm) are also observed due to the 
ambient air[56]. 
 
 
2.2. Experimental Setup 
DBD plasma was generated using a copper electrode core surrounded insulated by a 
teflon hollow cylinder and a quartz dielectric barrier as the high voltage electrode. A 
schematic of the experimental setup is shown in Figure 2-3. The copper rod core has a 
diameter of 25 mm; the thickness of the insulation cylinder is 10 mm and a 1mm thick 
quartz plate is used as the dielectric barrier. The samples were placed on a grounded plate 
and the air gap between the high voltage electrode and sample surface was adjusted to 1 
mm. The direct plasma treatment was done to a circle with the diameter of 25mm (core 
electrode diameter) in the center of the plate that is referred to as plasma treated area.  
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Figure 2-3.  A) Schematic view of the DBD plasma system. The DBD plasma system 
was used for the treatment of E. coli and MRSA cells in planktonic phase and in colonies. 
B) Image of DBD plasma system 
 
2.3. Electrical Characterization 
High voltage and current waveforms of the DBD plasma system were analyzed. A high 
voltage probe (1000:1) was utilized and connected to the plasma electrode in parallel. 
The high voltage cable was passed through a current probe (1 V/A) and by using digital 
oscilloscope (Tetronix. USA) the changes in voltage and current waveforms with time 
were recorded. Figure 2-4 is presenting the voltage and current waveforms over time. 
These kind of waveforms of voltage and current are typically observed as a result of  
electrical characterization of non-thermal DBD plasmas[60, 61]. These sinusoidal waves 
identify the micro-discharges ignited with 500 Hz frequency and 3 µs pulse width. The 
applied maximum high voltage output was 10 kV at 500 Hz and 3 µs pulse width (Figure 
2-4), with an applied power of 0.6 W.  
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Figure 2-4. DBD Plasma system voltage and current waveforms. Two cycles based on 
500 Hz frequency and 3 µS pulse width are shown. 
 
2.4. Optical Emission Spectroscopy 
Dielectric barrier discharge (DBD) in air was characterized using optical emission 
spectroscopy (OES) to detect the reactive species generated in the plasma in gaseous 
phase that are interacting with the treated samples. Optical emission spectroscopy was 
performed using a Jaz fiber optic spectrometer (Ocean Optics, Dunedin, FL).  The 
spectrometer used was a fitted with mercury argon calibration source (Ocean Optics), HG 
and Ar lines from 253-922 nm for calibration and, a 600 μm core diameter, QP600-1-
UV-VIS fiber to collect the light. The optical fiber was fixed in a position near the 
plasma glow and the emission spectrum was monitored. Data from the spectroscopy was 
transferred to the computer using SpectraSuite software (Ocean Optics, Dunedin, FL) via 
USB. This spectroscopy system allows the user to observe the entire spectrum instantly 
19
  
while doing the spectroscopy procedure. Spectrum data was then exported to Microsoft 
Excel for further analysis. Using Jaz spectrometer we could only detect molecular 
nitrogen peak because of their very high intensity. To get a closer look into the plasma 
and to be able to detect peaks with lower intensity we performed further spectroscopic 
measurements using iHR320 Imaging Spectrometer equipped with 1200 g/mm grating 
(750 nm blaze). The setup also contained Horiba Symphony II silicon CCD (liquid N2 
Cooled) and SynerJY software (written by Horiba within Origin) was used to transfer the 
data to computer. The emission spectrum was monitored at wavelengths between 200–
900 nm and is presented in Figure 2-5. 
Figure 2-5. Emission spectrum of the DBD plasma. The OH molecular spectrum (~306–
310 nm), N2 molecular spectrum (~330–425 nm), and excited oxygen atom emission 
lines (~777 and 844 nm) are also observed due to the ambient air. 
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Diagnostics of the reactive species in gaseous phase produced by DBD plasma were 
performed by optical emission spectroscopy [53]. As shown in Figure 2-5, the OH 
molecular spectrum (~306–310 nm), N2 molecular spectrum (~330–425 nm), and excited 
oxygen atom emission lines (~777 and 844 nm) were observed because the plasma was 
generated in ambient air. During the experiments, we detected NO metabolite Nitrite 
(NO2) in liquid phase confirming the production of NO by the DBD plasma system. We 
expected to detect NO bands in the range of 220-280 nm but it was not possible probably 
because of the low intensity of the peaks. 
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Chapter three 
Bactericidal effects of DBD Plasma Treatment on agarose gel 
3.1. Literature Review 
Wound infection is one of the most important challenges during the wound healing 
process. Infections caused by bacteria such as methicillin-resistant Staphylococcus aureus 
are of big concern because of the resistance to conventional treatments. DBD plasma is a 
candidate to be used for disinfection of the wounds because of the intrinsic properties of 
generated plasma and the flexibility of the application of atmospheric plasma in ambient 
air and ability of using the treatment target as a ground. During in vitro experiments that 
is also the focus of this study; the surface of agarose gel is being used to inoculate 
bacteria as a substance that can resemble the tissue. 
Application of various non-thermal plasma systems for decontamination is a growing 
field in plasma medicine and many studies are being implemented on this issue in the 
past decade. Alexeff et al. [62] published a work on the decontamination effects of 
Atmospheric pressure DC discharge on Escherichia coli, Pseudomonas fluorescens 
(5RL), and Wild type standard Lambdaphage on surface of agar plates. They utilized a dc 
steady state atmospheric pressure with water cooled resistive Barrier discharge apparatus 
and they report 100% decontamination of the species in less than 10 minutes. They 
observed faster sterilization with the hydrogen peroxide vapor diffusion process.  
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Burts, et al. [63]  introduced another plasma system using 2 planar electrodes and a low-
frequency alternative current (120 V, 60 Hz) fed through a step transformer (output 
voltage: 15 KV across secondary terminals at 60 mA). The working medium in the 
plasma reactor was air and traces of water vapor or hydrogen peroxide. a rotary blower 
was housed in the upper glass to circulate the generated ozone and other plasma produced 
species during plasma discharge. They tested the effectiveness of this plasma system on 
killing S aureus, including USA300 strains, and at disinfecting experimentally 
contaminated hospital pagers. They report up to a 4- to 5-log10 killing of bacteria on 
tryptic soy agar plates within 10 minutes on after Exposure of S aureus to plasma at 
different concentrations and for varying lengths of time. As they observed USA300 
strains of MRSA were more resistant to plasma-based killing than other tested strains. In 
addition they could achieve Disinfection of hospital pagers experimentally coated with 
clinically relevant amounts of MRSA in as little as 30 seconds. 
Ayan et al. [64] investigated the antimicrobial effectiveness of a nanosecond-pulsed 
dielectric barrier discharge (DBD) compared to was that of a microsecond-pulsed DBD. 
They implemented their research on E. coli and applied the bacteria on a topographically 
non-uniform agar Surface. Keeping the power and treatment duration constant, they 
demonstrated that nanosecond-pulsed DBD inactivates bacteria faster and over a waster 
surface area than the microsecond-pulsed DBD. They also reported that direct plasma 
treatment in which that electrical charges come in contact with the target is more 
effective than indirect plasma. 
 
Kostv et al. [65] used DBD plasma setup to observe the sterilization effect of the DBD 
plasma treatment on E. coli and Staphylococcus aureus in planktonic phase on agar plates 
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. They utilized a 60 Hz DBD reactor and the high voltage electrode area was covering the 
whole petridish. Their original concentration of the bacterial culture was 104 CFU/ml and 
they report complete sterilization for both species in less than 20 min. 
A comprehensive study on the biocidal efficacy of dielectric barrier discharge plasma on 
of E coli, S aureus, and methicillin-resistant Staphylococcus aureus had been 
implemented by Suresh G. Joshi et al. [66]. They inoculated overnight bacterial cultures 
on trypticase soy agar (TSA) and plasma treated the plates to observe the inhibition zone. 
To analyze the efficacy of treatment on bacterial cells in suspension they plasma treated 
cell suspension in PBS and used colony counting assay to analyze the efficacy. In order 
to test the bactericidal effects of plasma treated liquid they plasma treated PBS and 
immediately mixed it with cell suspension. . They also examined the efficacy of 
treatment on air dried samples of E. coli or S. aureus on concavity or monocavity glass 
slides. They reported more inactivation upon direct plasma application than using plasma 
treated PBS. Moreover they declared that E. coli was significantly more susceptible as 
compared to S. aureus. Their results indicate that in planktonic phase, E. coli, S. aureus, 
and MRSA were completely disinfected in 120 seconds. They reported the bactericidal 
efficacy of plasma treatment was exposure-time dependent, and cell density dependent.  
 
Hu Miao et al. [67]  investigated sterilization of E. coli (ATCC8099) using an 
atmospheric pressure, air DBD plasma at 100 Hz and 17 kV. E. coli (ATCC8099) 
suspension with the concentration between 1.0×106 CFU/ml and 5.0×106 CFU/ml were 
spread on sterile films of medical PTFE, PVC and PET with a size of 20mm×20mm and 
plasma treated for 1 to 5 min.  After the treatment, samples were washed with phosphate 
buffered saline (PBS) and colony counting was performed to determine the inactivation 
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rate. The results were reported as germicidal efficiency. 99.999% germicidal efficiency 
was reported after 5 min plasma treatment on PET films. As cell morphology was 
monitored by transmission electron microscopy (TEM), they report etching of cell 
membrane by electrons, ions and radicals as the primary reason of DBD air plasma 
sterilization. 
Tim Maisch et al. [68] used non-thermal plasma that is ignited by surface micro 
discharge (SMD) plasma technology using ambient air. High voltage of 9 kV with 1 kHz 
frequency was used and the system was enclosed in a plastic box. Deinococcus 
radiodurans and methicillin-resistant Staphylococcus aureus suspensions with the 
concentration of 107 CFU/ml were prepared. 20 µl of each serially diluted aliquot were 
dropped on and spread on agar plate. The inoculated agar plates (samples) were placed in 
the plasma device and treated for 20, 40, 60, 120, and 300 s. the number of viable 
colonies were counted after 24 or 48 hours. They report a 99.999 % inactivation of 
bacterial cells for both D. radiodurans and MRSA. As they observed UVC radiation did 
not inactivate D. radiodurans. Utilizing the same plasma system along with another 
portable plasma system using SMD plasma technology, Tim Maisch et al. [69] 
investigated  decolonization of MRSA, S. aureus and E. coli by non-thermal atmospheric 
plasma on a porcine skin model in vitro. They report 3log10 steps reduction after 6min of 
plasma treatment and with longer treatment times they could reach 5log 10 steps 
reduction.  By using the TUNEL-assay they confirmed that no significant degree of 
necrosis or apoptosis was determined. These results indicated that the porcine skin 
remains vital after plasma treatment which suggests that atmospheric non-thermal plasma 
is a possible method to decolonize bacteria on human tissue. 
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In this study, we hypothesized that the atmospheric pressure DBD plasma system will 
have a high antibacterial efficacy on methicillin-resistant staphylococcus aureus and 
Escherichia coli and investigated this matter by applying DBD plasma on these species   
in planktonic phase and also in colonies which was not done before. The plasma treated 
samples were also examined to investigate whether any secondary resistance to plasma 
treatment will be induced in bacteria. Also the efficacy of the treatment was evaluated on 
cells in suspensions with relatively high concentrations.   The flexibility of this DBD 
plasma system to use in ambient air makes it a very good candidate to be further utilized 
to decontaminate the areas of interest on human tissue which was exposed to the 
pathogens.  Studies has been done on the bactericidal effect of non-thermal plasma 
treatment on bacterial strains in planktonic phase but the antibacterial effects of DBD 
plasma treatment on colonies has not previously been investigated in the literature. In this 
study we are testing the DBD plasma treatment effect on bacterial colonies and we expect 
to see higher resistance levels to plasma treatment in bacterial colonies compared to 
bacteria in planktonic phase. The aim of this chapter is to study the in vitro bactericidal 
efficacy of DBD plasma treatment on methicillin-resistant Staphylococcus aureus 
(MRSA) and Escherichia coli (E. coli) on agarose gel in planktonic phase and in 
colonies. 
3.2. Materials and Methods 
3.2.1. Bactericidal effects of DBD Plasma Treatment on bacteria in planktonic 
phase 
Bacterial Culture and Sample Preparation 
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To study the effect of plasma treatment on planktonic culture, One lyophilized cylinder of 
E. coli (NCTC 10538,Microbiologics) was rehydrated in super broth (SB) (Fisher 
Scientific, MA) and dehydrated pellets of MRSA strains ATCC BAA-1556, ATCC 
BAA-1717, and ATCC 33591 obtained from ATCC, were rehydrated in brain heart 
infusion (BHI) broth (Sigma-Aldrich, MO), tryptic soy broth (TSB) (Fisher Scientific, 
MA), and nutrient broth (Sigma-Aldrich, MO), respectively. Each culture was streaked 
onto an agar plate using sterile swabs and incubated at 37 °C for 24 hours. A single 
colony of each strain was then transferred and inoculated in liquid broth. It was then 
grown overnight on a shaker platform at 37°C. The culture was centrifuged and the 
supernatant was removed. The pellet was re-suspended in 20 ml of liquid broth with 15% 
glycerol and transferred to micro centrifugal tubes, maintained at -80°C, freezer for 
further use.  
Prior to plasma treatment, E. coli and MRSA samples were taken out from the -80°C 
freezer, thawed, and cultured in liquid broth overnight on a shaker platform at 37°C. The 
cultures were diluted to obtain a cell concentration of 108 CFU/ml. The concentration was 
confirmed by a microplate reader (SpectraMax Plus 384, Molecular Devices, CA) and 
verified by a colony counting assay. Serial dilutions of 107, 106, 105, 104, and 103 CFU/ml 
were prepared. 100 µl of each dilution (for E. coli and all MRSA strains) were spread 
over agar plates using sterile spreading beads. The plates were plasma treated for various 
times to study the antibacterial effect of the plasma treatment. 
 
Dielectric Barrier Discharge Plasma Treatment  
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Planktonic bacteria inoculated agar plates were placed on the grounded electrode and the 
high voltage electrode was adjusted to have a distance of 1 mm from the sample surface, 
as shown in Figure 3-1.  Samples were plasma treated for 15 sec, 30 sec and 60 sec. After 
plasma treatment, plates were incubated for 24 hours at 37°C for further characterization 
of the effect of the DBD plasma treatment. All of the experiments were performed in 
triplicates. In order to investigate the effect of plasma treatment on planktonic cultures, 
plasma treated plates where incubated and monitored daily during 72 hours to check for 
further bacterial growth on the plasma treated area.  
 
Figure 3-1. Planktonic bacteria inoculated agar plates were placed on the grounded 
electrode and the high voltage electrode was adjusted to have a distance of 1 mm from 
the sample surface.  Samples were plasma treated for 15 sec, 30 sec and 60 sec (all 
MRSA strains and E. coli). 
Bactericidal effect of plasma treatment 
In order to investigate the effect of plasma treatment on planktonic cultures, plasma 
treated plates where incubated and monitored daily during 72 hours to check for further 
bacterial growth on the plasma treated area. To investigate whether the effect of plasma 
treatment is bacteriostatic or bactericidal, after 24 hours of incubation the clear plasma 
treated area of each plate was swabbed using a sterile cotton swab and streaked on 
another sterile plate. The cloudy, covered area was also swabbed as a control and 
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streaked on a sterile plate (Figure 3-2). Plates were incubated for another 24 hour to 
analyze the effects of plasma treatment. 
 
Figure 3-2. The clear plasma treated area of each plate was swabbed using a sterile 
cotton swab and streaked on another sterile plate. The cloudy, covered area was also 
swabbed as a control and streaked on a sterile plate. (All MRSA strains and E. coli) 
Dosage dependency of the plasma bactericidal effect 
The effect of dosage on the DBD plasma treatment efficacy was studied. Dosage is 
defined as the energy density (𝐽 𝑐𝑚2⁄ ) which is the energy applied by the power supply 
during the plasma treatment on each centimeter square of the plasma treated sample. The 
minimum lethal dose was defined as the dosage by which the plasma treated area (that is 
equal to the 25 mm diameter area that was directly plasma treated) was sterilized and 
completely clear. If there were less than 10 colonies growing on the plasma treated area 
after 24 hours of post treatment incubation, the dosage was considered as sub-lethal dose. 
For this purpose MRSA BAA-1556 culture was prepared overnight. The culture was 
diluted to the concentration of  ~5×108 CFU/ml. 100 µl of the culture was pipetted on 
each agar plate and spread. The plates were treated for 3,6,12,15,20,30 and 60 seconds 
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and for frequencies of 0.5, 1, 1.5, 2 and 2.5 kHz. Plates were then incubated and 
monitored for three days post plasma treatment. 
3.2.2. Investigating Emergence of Secondary Resistance to Plasma Treatment in 
Bacterial Cells 
In organisms never exposed in a host to a specific drug primary resistance may occur. In 
contrast, it is only after the exposure of organisms to the drug that secondary resistance, 
also defined as acquired resistance, arises. One of the main motivations of this research is 
to introduce a treatment that unlike antibiotics is not inducing any secondary resistance in 
bacterial species. The main purpose of this study is to confirm that we are suggesting a 
treatment that is not inducing any secondary resistance in the sub-lethal dose treated 
bacteria. The effect of DBD plasma treatment on emergence of secondary resistance to 
plasma treatment on MRSA BAA-1556 was studied. For this purpose MRSA BAA-1556 
original culture was prepared on day one and incubated overnight on a shaker platform at 
37°C. On day two, the original culture was diluted to the concentration of ~5×108 
CFU/ml. 100 µl of the culture was then pipetted on each agar plate and spread. The plates 
were then treated for 6,12,15,20,30,40,50 and 60 seconds and for frequency of 1500 Hz. 
Plates are then incubated for 24 hours post plasma treatment. On day three, the plates 
were photographed to check the dependency of the inhibition zone on plasma treatment 
dosage and one colony from the sub-lethal dose plasma treated area was removed and 
transferred to fresh media and incubated overnight on a shaker platform at 37°C. At the 
same time 10 µl of the original culture is also transferred to fresh media and is incubated 
overnight on a shaker platform at 37°C. On day four, the culture made from the sub-lethal 
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dose treated colony and the sub-culture of original culture were plasma treated similar to 
day 2 (Figure 3-3). On day five, the plates were photographed to analyze the dependency 
of the inhibition zone on plasma treatment dosage and compare the results to day 3 to see 
if any secondary resistance to the plasma treatment has occurred in the bacteria. If for a 
constant dosage, the inhibition zone becomes smaller on the plasma treated plates 
prepared with the culture made from sub-lethal dose treated colony compared to the 
plasma treated plates prepared with sub-culture of the original culture; one can conclude 
that the bacteria formed secondary resistance to plasma treatment 
 
Figure 3-3. Plasma treatment of original MRSA BAA-1556 culture and the culture 
prepared from the plasma treated colony 
3.2.3.  Bactericidal effects of DBD Plasma Treatment on Bacterial Colonies 
Bacterial Culture and Sample Preparation 
In order to evaluate the effect of plasma treatment on bacterial colonies E. coli and 
MRSA ATCC BAA-1556 as the most resistant strain to plasma treatment in planktonic 
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phase were used. Samples were taken out of the -80°C freezer, thawed, and cultured 
overnight in SB and BHI, respectively, on a shaker platform at 37°C. Cultures were 
diluted to reach a cell concentration of 108 CFU/ml. These concentration figures were 
verified with microplate reader. Serial dilutions of 103 and 104 CFU/ml of each culture of 
E. coli and MRSA were prepared. 100 µl of each dilution was spread over sterile SB and 
BHI agar plates respectively, using sterile spreading beads. Then the agar plates were 
incubated at 37°C for 12 hours until the colonies had grown and were visible on the 
plates. The plates were then plasma treated to study the bactericidal efficacy of the 
plasma treatment.  
 
Dielectric Barrier Discharge Plasma Treatment  
For bacterial colonies, inoculated agar plates were incubated for 12 hours to grow 
bacterial colonies on agar. The agar plates were placed on the grounded electrode and the 
high voltage electrode was adjusted to a distance of 1 mm from the sample surface. Plates 
were treated with DBD plasma for 1, 2, 3, 4, and 5 min, with untreated (0 min) samples 
as control. Microbiological analysis and quantification of the surviving populations of 
bacteria were performed. 
Measurement of the diameter of the colonies following plasma treatment 
To analyze the effects of the plasma treatment on colonies, the untreated control colonies 
and plasma treated colonies were monitored. After plasma treatment, plates were 
incubated for another 12 hours to observe the effect of the treatment (Figure 3-5), after 
which the respective sizes of treated and untreated colonies were measured and 
32
  
compared. For the purpose of this comparison, the diameters of the colonies before and 
right after treatment, and after 12 hours of incubation after the treatment were measured, 
in addition to the diameter of control colonies. The diameter of at least 10 colonies from 
each group was measured and the values are shown in the results (Figure 3-6) as the 
mean ± standard deviation. Statistical analyses were performed using t-test. The size of 
each group of treated colonies was compared to the size of the control group. The P 
values of less than 0.05 were considered to be statistically significant. 
Quantification of the Viable CFUs within Plasma Treated Colonies 
To determine the number of viable CFUs in each plasma treated colony, single colonies 
of E. coli and MRSA (BAA-1556) were plasma treated for 1, 2, 3, 4 and 5 minutes. Then, 
colonies were scrapped off and removed from the agar plates using sharp sterile needle 
tip and transferred to 1 ml of liquid media. The suspension was homogenized by pipetting 
up and down and then vortexing. Serial dilution was performed for the suspension and 
100 µl of each dilution was inoculated on agar plate and incubated at 37°C for 24 hours 
(Figure 3-4) to quantify the viable CFUs in each colony. To assess the decontamination 
efficacy of the treatment, 0 minute treated colonies as control were scrapped off and 
removed from the agar plates and transferred to 1 ml of liquid media. Serial dilution and 
colony counting were performed and the number of viable CFUs in untreated colonies 
was calculated. 
Assessment of Regrowth of Plasma Treated Colonies in Fresh Media  
To study the regrowth of viable bacterial cells, a second series of plates was seeded with 
~2 × 103 CFU/ml of bacteria and incubated for 12 hours till the colonies were formed. 
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Colonies were then treated with DBD plasma for 1, 2, 3, 4 and 5 min, with an untreated 
plate as a control. Immediately after the exposure, single colonies were scraped off of the 
plasma treated area and control (with a bit of agar to ensure collection of the entire 
colony) using sharp, sterile needle tip. The colonies were removed from the agar plate 
and transferred into 4 ml of liquid media and incubated on a shaker platform at 37°C. The 
regrowth was monitored by reading the absorbance at 600 nm (OD600) every 20 min for 
140 minutes for MRSA and 200 minutes for E. coli (Figure 3-4). The dynamics of the 
bacterial growth were measured by plotting the cell growth (absorbance) against the 
incubation time. Using this OD600 value and the standard curve of each bacterial species, 
a standardized regrowth curve of each treated colony was plotted. 
 
Figure 3-4. Experimental procedures to study bactericidal effect DBD plasma treatment 
on bacterial colonies (MRSA BAA-1556 and E. coli).A) Measurement of the diameter of 
the plasma treated colonies) Assessment of regrowth of plasma treated colonies in fresh 
media. C) Quantification of the viable CFUs within plasma treated colonies 
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3.2.4. Penetration of DBD Plasma-Generated Nitric Oxide into Agarose Gel  
Vertical penetration of DBD Plasma-Generated Nitric Oxide into Agarose Gel 
A Griess Reagents Kit (Molecular Probe, Life Technologies, CA) was used to study the 
penetration of nitric oxide in depth into agarose gel after plasma treatment. Agar plates 
with the thickness of 2, 4, 6, 8 and 10 mm were prepared. Samples were plasma treated 
for 120 sec. to investigate if the plasma-generated nitric oxide was diffusing in depth. The 
samples were then cut and flipped over and with the bottom surface facing up. 100 µl of 
each reagent, R1 and R2, were pipetted on the bottom surface of the plasma treated gel, 
was spread and incubated for 15 min to allow the diffusion of the reagents in the agar and 
reaction and color change to happen (Figure 3-5) 
 
Figure 3-5. Experimental procedure to examine penetration of Nitric oxide in agarose gel 
depth 
 
Radial Penetration of DBD Plasma-Generated Nitric Oxide into Agarose Gel with 
Bacterial Colonies 
To study the penetration of the nitric oxide in agar containing bacteria after plasma 
treatment, a series of agar plates was prepared and seeded with ~2 × 103 CFU/mL of 
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bacteria and incubated for 12 hours, after which the plates were treated with DBD plasma 
for 1,2,3,4, and 5 min. A Griess Reagents Kit (Molecular Probe, Life Technologies, CA) 
was used to study the penetration of nitric oxide into agarose gel after treatment. 100 µl 
of each reagent, R1 and R2, were pipetted on the plasma treated plate, was spread and 
incubated for 15 min to allow the diffusion of the reagents in the agar and reaction and 
color change to happen (Figure 3-6). 
 
Figure 3-6. Experimental procedure to study the radial penetration of Nitric oxide in 
agarose gel 
 
3.3. Results and Discussion  
In current study the decontamination efficacy of DBD plasma treatment on E. coli and 
MRSA species was investigated in a planktonic phase and in colonies. Results 
demonstrated that DBD plasma can decontaminate antibiotic resistant species. 
 Plasma is a cocktail of agents capable of accomplishing decontamination with a high 
concentration of reactive oxygen and nitrogen species, such as nitric oxide, hydrogen 
peroxide, and hydroxyl. [70]In addition to the strong electric field between the closely 
spaced electrodes, two central mechanisms have been implicated in decontamination by 
plasma: the reactive species that are generated in the plasma can deactivate the bacterial 
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cells either through direct physical bombardment of the membrane or by diffusing 
through the bacterial cell membrane and reacting with the membrane [38, 71].  
The DBD plasma system was created and electrically characterized. Further the DBD 
plasma was used to treat E. coli and MRSA in planktonic phase and in colonies for 
various treatment times. Results confirmed that DBD plasma treatment is 
decontaminating all the strains in planktonic phase and is inducing damage to the 
bacterial cells in colonies. The relation between the plasma dosage and decontamination 
of bacteria was confirmed and it was demonstrated that no secondary resistance is 
emerging in the bacteria after one generation. Finally results indicated that nitric oxide is 
penetrating more in the plasma treated agar plates radially on surface and in depth with 
increasing the treatment times.  
3.3.1. Bactericidal effects of DBD Plasma Treatment on Planktonic Bacterial 
Culture 
The Efficacy of DBD Plasma Treatment on Planktonic Bacterial Culture  
The planktonic cultures of MRSA and E. coli were treated for various times by DBD 
plasma. The decontamination effect of the plasma treatment on planktonic bacteria is 
represented in Figure 3-7. The plasma treated area is defined as a 25 mm circle in the 
center of each plate seeded (yellow dotted circle) on which the plasma is applied directly. 
After 60 sec of plasma treatment, plates seeded with the planktonic culture with the 
concentration of 108 CFU/ml cultures of all strains of MRSA at showed a complete 
decontamination on the plasma treated area which had a bacterial surface density of 1.27 
× 105 CFU/cm2 (Figure 3-7). No bacteria growth took place on the plasma treated area 
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after 24 hours of incubation. This happened for E. coli cells after 30 sec of treatment 
(Figure 3-7). These results indicate that MRSA strains are more resistant to plasma 
treatment than E. coli. By decreasing the bacterial concentration and increasing the 
treatment time the size of clear decontaminated area increases and will eventually grows 
bigger than the size of the  direct plasma treated area (that is equal to the core electrode 
area). This can be explained by means of the diffusion of reactive species beyond the 
electrode area. This means the effect of the reactive species in the decontamination 
process is chemical and not just related to the physical bombardment of the bacterial cells 
with ions, or charged particles.  
 
 
Figure 3-7. Plates seeded with planktonic bacterial culture with the concentrations of 
~10
8 CFU/ml creating a bacterial surface density of ~ 10
5 CFU/cm2. It can be seen that 
complete sterilization on the plasma treated area that is specified with the dashed circles 
is achieved for E. coli after 30 seconds and for MRSA ATCC BAA-1556, MRSA ATCC 
BAA-1717 and MRSA ATCC 33591 after 60 seconds of plasma treatment 
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Bactericidal effect of plasma treatment 
Bactericidal drugs kill bacteria directly while bacteriostatic drugs simply stop the 
bacterial growth. Upon removal of the bacteriostatic agent, the bacteria usually start to 
grow again.  To test the bactericidal effect of the plasma treatment, plasma treated 
bacterial culture were transferred from plasma treated area that is decontaminated and 
clear, to a new agar plate by swabbing to engender the opportunity to grow in the absence 
of antibacterial agents introduced to the agar plate following the plasma treatment. The 
agar plates are monitored for 72 hours; no bacterial growth occurred. As a control the 
untreated area was also swabbed and streaked on a new agar plate; after 24 hours of 
incubation bacterial growth could be seen (Figure 3-8).This may suggest that the plasma 
treatment has a bactericidal effect during the decontamination process. 
 
 
Figure 3-8. A) MRSA (ATCC BAA-1556) culture on agar after treatment and 24 hours 
of post treatment incubation. The plasma treated area that is specified with the dashed 
circle is completely clear. B) Untreated area was swabbed and streaked on a sterile agar 
plate. After 24 hours of post treatment incubation, bacterial growth is present. C) 
Plasma treated area was swabbed and streaked on a sterile agar plate. No bacterial 
regrowth was seen after 3 days of post treatment incubation. 
Dosage dependency of the bactericidal effect of plasma 
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This experiment was designed to investigate the dosage dependency of the 
decontamination associated with plasma treatment. In a constant voltage, the total power 
that is applied on the plasma treated target depends on the duration of treatment and 
frequency of the applied voltage. Dosage is defined as the energy density (J/cm2) which 
is the energy applied by the power supply during the plasma treatment on each centimeter 
square of the plasma treated sample. The minimum lethal dose was defined as the dosage 
by which the plasma treated area (that is equal to the 25 mm diameter area that was 
directly plasma treated) was sterilized and completely clear. After plasma treatment, the 
decontaminated area on the agar plate is referred to as inhibition zone. The size of 
inhibition zone deferred depending on the dosage of plasma treatment which is stated as 
energy density. In order to better analyze the results of the experiment three sterilization 
levels were defined. In case more than 10 viable colonies grew on the plasma treated area 
following 24 hour post treatment incubation, we assumed we had “No sterilization”. If 
less than 10 viable colonies grew on the plasma treated area following 24 hour post 
treatment incubation “Partial sterilization” had happened and the corresponding dosage 
was alled “Sub-lethal dose”. Finally if no colony grew on the plasma treated area and the 
inhibition zone is exactly equal to plasma treated area  “Complete Sterilization” had 
happened and the corresponding dosage was reffered to as “lethal dose”. 
Figure 3-9 represents dependency of the bactericidal efficacy of plasma treatment on the 
plasma dosage. The black dotted circles are representing the plasma treated area. It can be 
seen that the bactericidal efficacy of plasma treatment is highly dosage dependant. 
Results confirm that increasing the dosage will enhance the bactericidal effects of plasma 
treatment on the plasma treated area.   
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Figure 3-9. Bactericidal efficacy of plasma treatment in dependent on the plasma dosage 
for MRSA BAA-1556. The dotted circle is representing the olasma treated area. A)in 
table A the compeletly sterilized, not sterilized and partially sterilized samples are 
indicated with letters “C”,”N” and “P” respectively.B) table B shows the  treatment 
Dosage which is defined as the energy density(J/cm2) It can be seen that the bactericidal 
efficacy of plasma treatment is dosage dependant(MRSA ATCC-1556). In the first table, 
N, P and C stand for “No sterilization”, “Partial sterilization(less than 10 viable 
colonies)(Sub-lethal dose)” and “Complete Sterilization( lethal dose)” respectively. 
 
. 
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3.3.2. Investigating Emergence of Secondary Resistance to Plasma Treatment in 
Bacterial Cells 
 
Comparing results from day 5 to day 3, no significant difference was observed between 
the bactericidal efficacy of plasma treatmtent on the plates seeded with original MRSA 
ATCC-1556 culture and sub-culture of original culture and plates seeded with the culture 
prepared from sub-lethal dose plasma treated colony (Figure 3-10). This suggests that no 
secondary resistance to plasma treatment is emerging in the bacteria after one generation.  
 
 
 
Figure 3-10. Comparing results from day 5 to day 3 no significant difference was 
observed between the bactericidal efficacy of plasma treatment on the plates seeded with 
original culture and sub-culture of original culture and plates seeded with the culture 
prepared from sub-lethal dose plasma treated colony (MRSA ATCC-1556) 
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3.3.3. Bactericidal effects of DBD Plasma Treatment on Bacterial Colonies 
The Efficacy of DBD Plasma treatment on Bacterial Colonies  
The decontamination effect of the plasma treatment on bacterial colonies is represented in 
Figures 3-11 and 3-13. The black circles on the plates are showing the plasma treated 
area. The small marks on the plasma treated area are voids of the scrapped off and 
removed colonies for further characterization. As shown, E. coli colonies completely 
stopped growing after 5 min of plasma treatment. For 5 min treated MRSA strain ATCC 
BAA-1556, the size of the colonies is approximately unchanged after 24 hours of 
incubation at 37 °C. For shorter treatment times, colonies had grown after 24 hours of 
post treatment incubation at 37 °C. However, growth in the treated colonies was less 
substantial than in the untreated colonies after 12 hours of incubation, and as the amount 
of treatment time increased, the level of growth in the colonies decreased, when 
measured after 24 hours of post treatment incubation at 37 °C.  
 
 
Figure 3-11. A) E. coli colonies incubated for 12 hours. After colonies are grown for 12 
hours, they are plasma treated for 1 to 5 min to observe the effect of plasma treatment on 
the colony growth process. B, C, D,E) E. coli colonies after  1,3 and 5 minutes of 
plasma treatment and an additional 12 hours of post treatment incubation. The black 
circles are showing the plasma treatment area. Results demonstrated that the colonies in 
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the plasma treated area are less grown compared to untreated colonies that had gone 
through the normal growth process. 
 
Figure 3-12. First bar is representing the diameter of the colonies before plasma 
treatment. The rest of the bars are showing the final diameter of E. coli colonies after 
additional 12 Hours of post treatment incubation. The results are expressed as mean ± 
standard deviation of at least 10 samples. * denote statistical differences from the 
untreated group. (P<0.0001(t-test)) 
 
Figure 3-13. A) MRSA BAA-1556 colonies incubated for 12 hours B) 0 min MRSA 
colonies after 12 hours of post treatment incubation C) MRSA colonies after 5 minutes 
of plasma treatment and an additional 12 hours of post treatment incubation. The 
colonies in the plasma treated area that is specified with the dashed circles are less 
grown compared to the colonies outside of the plasma treated area.  
The minimum time needed to decontaminate MRSA cells in planktonic phase completely 
was 60 seconds so this time was chosen as the minimum treatment time to treat the 
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colonies. Results demonstrated longer treatment times are required to decontaminate the 
bacterial cells in colonies than in planktonic phase. The reason could be high cell 
densities in colonies and the fact that bacterial cells in colonies are encased in a 
polysaccharide matrix and as a result more resistant [72]. Colonies were treated for 1, 2, 
3, 4 and 5 minutes. For all the treatment times the plasma treated E. coli colonies are 
showing less growth in size 24 hours after plasma treatment compared to untreated 
colonies (Figure 3-11). Also for MRSA colonies the final diameter of the plasma treated 
colonies after 24 hours post treatment incubation are less that the diameter of untreated 
colonies (Figure 3-13). Figure 3-12 shows the final diameter of the E. coli colonies 
incubated for 12 hours following various lengths of plasma treatment. The final diameter 
of the E. coli colonies incubated for additional 12 hours post plasma treatment decreased 
as the treatment time had increased. The diameter of the E. coli colonies before treatment 
is 0.88 ± 0.13 mm, which is slightly greater than the diameter of colonies after 5 min of 
treatment followed by 12 hour post treatment incubation. This could represent some level 
of shrinkage in colonies due to bacterial cell damage after 5 min of plasma treatment.  
 
Quantification of the Viable CFUs in Plasma Treated Colonies 
Colonies were plasma treated on the agar plates for 1 to 5 min with 0 min treatment time 
as control and were scraped off and transferred to 1 ml of fresh media. Serial dilution was 
performed and dilutions were plated. Colonies were counted after 24 hours and 
calculations were done to find the number of viable CFUs in each colony. Samples were 
prepared in triplicate and at least three colonies from each plate were cut and the number 
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of CFUs in each was calculated. The results for E. coli and MRSA colonies are shown in 
Figures 3-14 and 3-15 respectively. The values are mean ± standard deviation of at least 
10 samples. Figure 3-14 demonstrates that after quantification of the number of viable 
CFUs in plasma treated colonies, results indicate that for E. coli colonies 7 log reductions 
is happening after 4 and 5 minutes of plasma treatment in all the colonies in the plasma 
treated area. It can be seen in Figure 3-15 that for MRSA colonies 3 to 7 log reductions 
are happening after 5 minutes of plasma treatment This means that the effect of plasma 
treatment is not distributed uniformly on all the colonies and longer treatment time or 
higher dosage is needed to induce equal levels of decontamination in all the MRSA 
colonies on the plasma treated area. The results show that MRSA colonies show more 
resistance to plasma treatment compared to E. coli cells. In both cases significant 
reduction in the number of cells in colonies was achieved after 1 minute of plasma 
treatment and monitoring the regrowth of treated colonies in liquid media justifies this 
finding. Longer treatment time or higher dosage is needed to achieve complete 
inactivation of MRSA colonies.  
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Figure 3-14. Number of viable CFUs of E. coli in each colony after various treatment 
times. The results are expressed as mean ± standard deviation of at least 7 samples. * 
denote statistical differences from the untreated group. (P<0.0001(t-test))  
 
Figure 3-15. Number of viable CFUs of MRSA BAA-1556 in each colony after various 
treatment times. The results are expressed as mean ± standard deviation of at least 7 
samples.* denote statistical differences from the untreated group. (P<0.0001(t-test)) 
.  
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Assessment of Regrowth of Plasma Treated Colonies in Fresh Media  
Colonies were cut and removed from the agar plate after treatment and transferred into 4 
ml of liquid media and incubated on a shaker platform at 37°C. The growth was 
monitored. The influence of the plasma treatment on the regrowth ability of treated E. 
coli and MRSA colonies is represented in Figures 3-16 and 3-17. Results show that the 
plasma treated colonies has longer lag time in the growth process in fresh media. 
The length of the lag phase in bacterial growth is dependent on a variety of factors 
including change in physiology and nutrient and time to recover from shock in the 
transfer that we assume should be present for all the transferred colonies [73].Time 
needed for recovery from damage and the size of the inoculum which means the number 
of cells in each colony that are dividing normally, are two other important factors 
influencing the length of the lag phase[74]. Growth curves for colonies treated for various 
times are showing that colonies treated for longer times has a longer lag phase which can 
be interpreted as more damage is induced to the colonies with increasing the treatment 
time. No regrowth of 4 and 5 min treated E. coli cells in colonies is observed in fresh 
media after 200 minutes incubation on a shaker platform at 37°C (Figure 3-16) However, 
monitoring the regrowth of MRSA colonies in fresh media for 140 minutes confirmed 
that extended treatment time is required to inactivate all the cells in MRSA colonies 
(Figure 3-17). 
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Figure 3-16. Regrowth of E. coli Colonies in SB Media after Plasma Treatment. Treated 
colonies were transferred to fresh media and the regrowth was monitored by reading the 
OD 600 of the cultures each 20 minutes. Results are expressed as mean± standard 
deviation of 4 samples. 
 
Figure 3-17. Regrowth of MRSA BAA-1556 Colonies in BHI Media after Plasma 
Treatment. Treated colonies were transferred to fresh media and the regrowth was 
monitored by reading the OD 600 of the cultures each 20 minutes. Results are expressed 
as mean± standard deviation of 4 samples. 
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3.3.4. Penetration of DBD Plasma-Generated Nitric Oxide into Agarose Gel  
Vertical penetration of DBD Plasma-Generated Nitric Oxide into Agarose Gel  
Following 120 sec of DBD plasma treatment, NO2 is detected in the agarose gel for 2, 4, 
6, 8 and 10 mm depths. Nitrite (NO2) is the stable metabolite of NO especially in vitro 
[75], thus the results confirm penetration of NO associate with DBD plasma treatment in 
depth (Figure 3-18).  It can be seen that nitric oxide penetrates deeper in the agarose gel 
with longer plasma treatment times. This indicates that with prolonged treatment time, 
more nitric oxide is induced into the solid agar, and this can assist the inactivation of the 
microorganisms in depth. 
 
 
Figure 3-18. Diffusion of plasma associated nitric oxide in agarose gel. Pictures are 
taken after plasma treatment and flipping the agar upside down and putting the Griess 
reagents on, so in all the pictures bottoms are up. Implementation of Griess assay 
confirms the penetration of NO to the depth of 10 mm of agarose gel. The thickness of 
the glass slide is 1 mm.  
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Radial Penetration of DBD Plasma-Generated Nitric Oxide into Agarose Gel with 
Bacterial Colonies 
 
Nitric oxide distribution on the plasma treated agar for various treatment times is 
represented in Figure 3-19. Color change is indicative of the diffusion of nitric oxide and 
presence of nitrite in the area. The nitric oxide diffusion area and the color intensity grew 
with increasing the plasma treatment time. The nitric oxide diffusion area was measured 
using threshold colour plugin from the public ImageJ software (National Institutes of 
Health (NIH), USA). Images were converted to 8-bit greyscale and their threshold was 
adjusted so that the colored area was showing distinctively. The picture was then 
analyzed and the diffusion change area was measured. After 3 minutes of plasma 
treatment, the area grew bigger than the directly plasma treated area that is equal to core 
electrode area. In the cases of longer treatment times, reactive species might reach 
beyond the direct plasma treated area either in gaseous phase or by penetrating further 
into the agarose gel along the surface and in depth. It can be seen that the nitric oxide 
diffusion area became broader as treatment time increased. This indicates that with 
increased treatment time, more nitric oxide penetrates into the solid agar, and this can 
cause the area of decontamination to widen. Having a sterilized area broader than the 
direct plasma treated area means that the antibacterial effect of plasma treatment 
chemical and not only a result of the physical bombardment of bacterial cells with 
charged particles. 
 
51
  
 
Figure 3-19. Diffusion of Nitric oxide in agarose gel is detected by applying Griess 
assay after 1, 2, 3, 4 and 5 min of plasma treatment. Plasma treated area is specified 
with the dashed circles. The diffusion area grows bigger with increasing the 
treatment time. The areas were measured using ImageJ software. 
3.4. Summary 
4. The effect of cold plasma treatment on the decontamination of MRSA and E. coli 
in a planktonic culture and colonies were studied. Cold plasma treatment is a bactericidal 
treatment and is an effective way for inactivating E. coli and MRSA strains ATCC BAA-
1556, ATCC BAA-1717 and ATCC 33591 in planktonic phase and in colonies on agar 
surface.  Longer treatment times are needed to observe a uniform distribution of 
treatment effect on the treated area. For a given strain, longer treatment time is needed to 
completely inactivate bacteria in colonies than planktonic phase. With longer treatment 
times the reactive species like nitric oxide diffuse more into the agar radial and also in 
depth and results show growing in inhibition zone with longer treatment times. Having 
sterilized area that is bigger than the area of the electrode (which corresponds to the 
directly plasma treated area), implies that the effect of plasma on the cells should be 
chemical and not only dependent on the physical damage of the cells by bombardment of 
the cells with charged particles.  
52
  
 
Chapter four 
DBD Plasma Treatment of Aqueous Solution 
4.1.Literature Review 
 
Plasma treatment can be applied on the target in liquid phase directly or indirectly. This 
means the liquid solution containing bacterial cells can be plasma treated directly or the 
liquid with no bacteria was plasma treated can be plasma treated and used on the bacterial 
culture. 
J.H. Choi et al. published a study in which E. coli was suspended in 0.9% normal saline 
and dried for 2 hours on small cover glasses before plasma treatment [76]. DBD plasma 
treatment was done by 1 kHz negative pulse discharge of 11 kV with a 1mm gap for 0, 
10, 30, 50 and 70 s and after re-suspending the cells in normal saline following treatment, 
colony counting method was used to analyze the results. The results are as presented in 
Figure 4-1. Their results demonstrated that the plasma treatment is effectively 
inactivating bacterial solution that had been dried on surface before treatment. 
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Figure 4-1. Linear-fitting surviving number of CFU of E coli versus the treatment time 
for negatively pulsed DBD of 11 kV at 1 kHz, the replication numbers are three and the 
bars are standard error bars [73] 
 
In order to study the morphological change, cover glasses were coated by poly L-lysine 
to develop adhesion of the cells to the glass. E. coli suspensions were dried on glass and 
plasma treated. After treatment samples were coated with an ultra-thin layer of gold and 
morphologies observed by SEM (s-800, HITACHI, Tokyo, Japan) their results is 
represented in Figure 4-2. 
They report both chemical damage by ozone and reactive species and physical damage 
caused by ions bombardment are important during plasma sterilization. 
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Figure 4-2. SEM images of E. coli at each duration time for treatment in plasma (10000 
x magnification), a) 0 s b) 10 s c) 30 s d) 50 s and e) 70 s [73] 
 
 
Sterilization of A non-pathogenic strain of E. coli bacterium, K12, in air and water was 
studied by Gustol et al. [77]. Plate counting method was used to study the treatment 
efficiency. Using 108, 107, 106, 105 and 104 CFU/ml as concentration using sterile water, 
they report that inactivation efficacy of plasma treatment was strongly dependent to the 
initial concentration of the bacterial cells. The dosage required to reduce the number of 
viable bacteria to 90 %( D-value) also decreased with decrease in initial bacterial 
concentration. For an initial concentration of 104 CFU/ml that is considered a relatively 
low concentration, D-value as low as 125 J/L was obtained. Their results showing the 
dependency of E. coli deactivation efficiency by spark discharge in water on power input 
and on initial concentration of the bacteria were presented in Figure 4-3. Figure 4-3 
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shows that the bacterial log reduction associated with plasma treatment will increase by 
increasing the power and reducing the bacterial concentration.  
 
Figure 4-3. E. coli deactivation efficiency by spark discharge in water depending on 
power input and on initial concentration of the bacteria [74] 
 
Inactivation of Staphylococcus aureus suspended in liquid by Cold-atmospheric-pressure 
air plasma microjet was investigated by Liu et al.  [71] . The plasma system was 
sustained in a quasisteady gas cavity in a liquid medium. The pH value of the liquid was 
also monitored and after 10 min plasma treatment it had changed to steady-state value of 
3.0–4.5. They report that the decrease in the pH is associated with the reaction of NOx 
produced by plasma with water. After 20 minutes of plasma treatment the reported 
concentrations of NO3
- and NO2
- are 37 mg/ L and 21 mg/L, respectively. Their results 
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demonstrated that the inactivation of the bacteria had started as pH had decreased to 4.5 
after 10 min plasma treatment and 100% inactivation happened after 16 min plasma 
treatment and stable pH of 4.5.  
The DBD plasma ability to disinfect water was tested by K. Oehmigen et al. [78]. They 
utilized surface dielectric barrier discharge (DBD) in ambient air conditions with a pulsed 
sinusoidal voltage of 10 kV peak (20 kHz). Depending on the sample volume, they report 
complete inactivation of high concentrations (106 to 108 CFU/mL) of Escherichia coli 
and Staphylococcus aureus within 5–15 min. As they observed inactivation had just 
occurred in the non-buffered solutions which were acidified following plasma treatment. 
Monitoring the pH, nitrate, and nitrite concentrations associated with plasma treatment, 
they had concluded that the main source of liquid acidification is nitric acid formation. 
But since Incubation of bacteria in nitric acid alone did not cause comparable inactivation 
rates, synergistic action of both reactive oxygen and nitrogen species were reported to be 
responsible for antimicrobial plasma effects.  
 Based on K. Oehmigen et al. studies, Plasma treatment of bacteria in aqueous solutions 
induces chemical species such as nitrate, nitrite and hydrogen peroxide and change the 
pH. Thomas von Woedtke et al. [79]  tried to better explain the phenomena that cause 
bactericidal effect in aqueous solutions using experimental methods and 10 kV ignition 
voltage for the DBD system in air. They also analyzed possible interactions happening 
during plasma treatment of water theoretically. Escherichia coli NTCC 10538 solution 
with concentrations of 107 −108 in distilled water as well as sodium chloride had been 
used.  5 ml of the solutions were treated for up to 30 min and plate count method was 
used to estimate the number of viable bacterial cells. pH measurements were done and 
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Nitrite and nitrate and hydrogen peroxide concentrations were monitored. They 
demonstrated that acidification associated with DBD plasma treatment in air is mainly 
related to HNO2 production but they also had observed acidification in argon atmosphere 
that should be explained differently. Generally the detection of reactive species in plasma 
treated liquids needs further investigation and liquid analytics. 
 Friedman G. [80] has maintained a hypothesis about the creation of “plasma acid” which 
is associated with reactive oxygen species. Natalie Shainsky et al. [81]  further 
investigated this hypothesis on plasma acid. Utilizing a DBD plasma system with 17 kV 
pulse voltage and 1.7 KHz pulse Frequency in a closed cavity, they demonstrated that 
direct treatment of deionized water reduces the pH to 2 and created an acid that has the 
ability of peroxidation of a cell membrane. As the source of the acidification two major 
candidates were studied: nitric/nitrous acid and an acid that they had called plasma acid 
which consist of a hydrogen cation and a superoxide anion. Although the existence of 
nitric/nitrous acid in the water after plasma treatment in air had been confirmed, they 
explain that pH as low as 2 cannot be completely associated to the presence of nitric acid. 
In addition, the high acidity caused by oxygen –plasma cannot be related to nitrogen 
based acids. They concluded that O2
- should be partially involved in acidification and 
together with H2O2 they might be responsible for the oxidation properties of plasma 
treated water. Finally they suggest that plasma treated water can be potentially used in 
medicine because of its unique properties. 
 James R Ferrell et al. [82] used a  plasma generator(GPP) for treatment of bacteria in 
liquid media and on agar surface . The GPP has three main components: a control 
module, plasma wand and plasma nozzle. Air (as the working gas) was introduced into 
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the plasma generator. S. aureus ATCC 12598, P. aeruginosa ATCC 29260, Klebsiella 
pneumoniae ATCC 8045, Escherichia coli ATCC 25297, B. subtilis ATCC 465, and B. 
atrophaeus ATCC 6455 were plasma treated. They monitored the pH change of the 
bacterial suspension in liquid with depths and a diameter of 0.8 cm and 1.75 cm plasma 
treated from 15 seconds to 5 minutes and also spread plasma treated planktonic culture on 
agar plates.  As a result they observed that the environment surrounding the plasma 
treatment targets has a very important effect on the effectiveness of the antimicrobial 
agents produced by plasma. They reported that Staphylococcus aureus plasma treated for 
two minutes in low nutrient environment had lower survival rate compared to 
Staphylococcus aureus plasma treated in rich nutrient liquids like broth. 
Eisuke Takai et al. [83] offered another explanation for the sterilization effect of plasma 
treatment in liquid associated with pH reduction. For this purpose they used 
Streptococcus mutans JCM 5705, Campylobacter rectus JCM 6301 and Escherichia coli 
NBRC 3301 as target species and utilized a low-frequency (LF) plasma jet with helium 
gas flows and application of an alternating current high voltage (ranging from −3.5 to 
+5.0 kV at a frequency of 13.9 kHz). Bacterial cell density in distilled water was set to 7 
× 107 cells/ml of bacteria. It was then diluted 10-fold in buffer (pH range 6.5–3.7) and 
subsequently, 500 μl of this diluted solution was plasma treated in 24-well microplates. 
The number of viable bacterial cells was determined by colony counting method. They 
observed that the inactivation rate of the target bacteria was proportional to hydroperoxy 
radicals’ concentration in the plasma treated solution. As a result they reported that 
hydroperoxy radicals have the key role in the efficacy of bacterial inactivation associate 
with pH reduction as a result of plasma treatment.  
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To examine the bactericidal effects of DBD plasma treatment in liquid phase in this 
study, bacterial cells suspensions in sterile DI water were plasma treated. Also the DI 
water with no bacteria was plasma treated and bacterial solution was later exposed to this 
plasma treated liquid to investigate the indirect effect of plasma treatment and the 
possibility of using the plasma treated water as an antiseptic liquid. To further investigate 
the bactericidal mechanisms of plasma treatment in liquid phase, pH and the stable NO 
metabolite (NO2) concentration in the plasma treated samples were measured. 
Morphological changes of the plasma treated bacterial cells were also investigated using 
SEM. 
4.2. Materials and Methods 
4.2.1. Efficacy of DBD plasma treatment on bacteria in DI water 
Bacterial Culture and Sample Preparation 
To study the effect of plasma treatment on bacterial cells in suspension , One lyophilized 
cylinder of E. coli (NCTC 10538,Microbiologics) was rehydrated in super broth (SB) 
(Fisher Scientific, MA).the culture was streaked onto an agar plate using sterile swabs 
and incubated at 37 °C for 24 hours. A single colony was then transferred and inoculated 
in liquid broth. It was then grown overnight on a shaker platform at 37°C. The culture 
was centrifuged and the supernatant was removed. The pellet was re-suspended in 20 ml 
of liquid broth with 15% glycerol and transferred to micro centrifugal tubes, maintained 
at -80°C, freezer for further use.  
Prior to plasma treatment, E. coli sample was taken out from the -80°C freezer, thawed, 
and cultured in liquid broth overnight on a shaker platform at 37°C. The culture was 
centrifuged and the supernatant was removed. The pellet was re-suspended in 20 ml of 
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sterile DI water. The culture was diluted to obtain a cell concentration of 108 CFU/ml. 
The concentration was confirmed by a microplate reader (SpectraMax Plus 384, 
Molecular Devices, CA) and verified by a colony counting assay.  
To be able to control the depth of the suspension during plasma treatment, 5 cm× 5 cm 
aluminum plates with 10 mm diameter pockets on each were made. Plates were prepared 
with 1, 2, 3 and 4 mm deep pockets. The pockets were then filled up with the cell 
suspension in DI water and plasma treated to investigate the how the efficacy of plasma 
treatment changes with increasing the liquid depth. 
Dielectric Barrier Discharge Plasma Treatment  
The samples were placed on the grounded electrode and the high voltage electrode was 
adjusted to a distance of 1 mm from the sample surface. Samples were treated with DBD 
plasma for 0 (control), 30, 60, 90 and 120 sec. Serial dilutions were prepared and plated 
and plates were incubated for 24 hours in 37°C (Figure 4-4). Quantification of the 
surviving populations of bacteria was performed by colony counting. 
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Figure 4-4. Experimental procedure for investigating the bactericidal efficacy of DBD 
plasma treatment on E. coli bacterial cells in DI water suspension 
 
4.2.2. Bactericidal Efficacy of DBD Plasma Treated DI water 
Bacterial Culture and Sample Preparation 
To study the effect of plasma treatment on bacterial cells in suspension , One lyophilized 
cylinder of E. coli (NCTC 10538,Microbiologics) was rehydrated in super broth (SB) 
(Fisher Scientific, MA).the culture was streaked onto an agar plate using sterile swabs 
and incubated at 37 °C for 24 hours. A single colony was then transferred and inoculated 
in liquid broth. It was then grown overnight on a shaker platform at 37°C. The culture 
was centrifuged and the supernatant was removed. The pellet was re-suspended in 20 ml 
of liquid broth with 15% glycerol and transferred to micro centrifugal tubes, maintained 
at -80°C, freezer for further use.  
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Prior to plasma treatment, E. coli sample was taken out from the -80°C freezer, thawed, 
and cultured in liquid broth overnight on a shaker platform at 37°C. The culture was 
centrifuged and the supernatant was removed. The pellet was re-suspended in 20 ml of 
sterile DI water. In order to wash the bacterial pellet, the suspension was centrifuged 
again and the supernatant was removed and the bacterial pellet was re-suspended in 1 ml 
of sterile DI water and was diluted to obtain a cell concentration of 109 CFU/ml for 
further use. The concentration was confirmed by a microplate reader (SpectraMax Plus 
384, Molecular Devices, CA) and verified by a colony counting assay.  
Dielectric Barrier Discharge Plasma Treatment  
A 3 ml volume of sterile DI water was plasma treated for 120 seconds in a small sterile 
petridish with the diameter of 35 mm. 500 µl of the bacterial suspension with the 
concentration of 109 CFU/ml was then mixed and suspended in the plasma treated DI 
water and was incubated in room temperature for 30 minutes to further quantify the 
population of viable bacterial cells. 500 µl of the bacterial suspension with the 
concentration of 109 CFU/ml was also re-suspended in 3 ml of untreated DI water and 
incubated for 30 minutes as control. After 30 minutes exposure to plasma treated DI 
water, suspensions were centrifuged and the supernatant was removed. The remaining 
pellet was then re-suspended in 3.5 ml of fresh untreated sterile DI water. Serial dilutions 
were prepared and quantification of the surviving populations of bacteria was performed 
by colony counting (Figure 4-5). 
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Figure 4-5. Experimental procedure to study bactericidal efficacy of plasma treated DI 
water on E. coli  
4.2.3. pH measurement 
To measure the pH change in DI water that is associated with DBD plasma treatment, a 
Thermo scientific Orion micro pH meter (Thermo Fisher Scientific, Beverly, MA) 
attached to a accumet™ AP63 Portable pH Meter Kit(Fisher Scientific , Pittsburgh, PA) 
was used. All the measurements were performed in monitored room temperature. The 
Original pH of sterile DI water was measured first. A wide range of pH results were 
collected for DI water because of its intrinsic properties [84] . Samples were then plasma 
treated and the pH after plasma treatment for various times and in various volumes and 
different containers were investigated (Figure 4-6). 
To study the effect of different plasma treatment times on the pH change, Sterile DI water 
was plasma treated in the aluminum plates with a 10 mm diameter and 4 mm deep pocket 
for 30, 60 and 120 sec. The pH was then measured by means of the microprobe.  
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In order to investigate the effect of the liquid depth on the ability of plasma treatment to 
change the pH of liquid, plates with pockets with the depth of 1, 2, 3 and 4 mm and a 10 
mm cross section area were utilized. The pockets were then filled up with sterile DI water 
and the original pH of sterile DI water was measured first. Samples were then plasma 
treated for 60 sec and the pH was measured again.  
The aging effect on the change of pH after plasma treatment was also investigated. The 
pH of a 3 ml volume of DI water, plasma treated for 60, 90 and 120 sec in a small sterile 
petridish was monitored for 17 hours post treatment incubation in room temperature. 
In order to study the effect of DBD plasma treatment time on larger volumes of sterile DI 
water and longer plasma treatment times; 3, 15 and 50 ml volumes of DI water were 
plasma treated in sterile petridishes for 1,2 ,3, 4 and 5 minutes and the pH was measured. 
Simulated Body Fluid (SBF) which has ion concentrations nearly equal to those of 
human blood plasma was also prepared as previously described in literature[85]. Plasma 
treatment was done in 3 ml of SBF in small sterile prtridish for 1, 2, 3, 4 and 5 min to see 
how the plasma treatment will change the pH of a buffered solution. 
 
Figure 4-6. pH measurement of untreated and DBD plasma treated DI water 
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4.2.4. Griess Assay 
Penetration of DBD Plasma-Generated Nitric Oxide in DI water 
The plasma treatment was conducted at ambient environment. Studies showed that nitric 
oxide is likely the most well-known agent in decontamination when plasma is ignited at 
air [86, 87] . A Griess Reagents Kit (Molecular Probe, Life Technologies, CA) was used 
to study the penetration of nitric oxide into DI water after treatment. NO introduced to the 
samples after plasma treatment rapidly reacts with oxygen and  produce stable 
metabolites of nitrate (NO3) and nitrite (NO2), which can be measured by Griess 
reaction[88, 89]. 
To prepare the reagents for the experiment the contents of nitrate/nitrite assay buffer vial 
was diluted to 100 ml with ultrapure water and was stored at 4°C. This buffer was then 
used to dilute the samples prior to assay. Nitrate reductase enzyme and nitrate reductase 
cofactors were reconstituted with 1.2 ml of Assay buffer and was stored at -20°C for 
further use. Lyophilized nitrate and nitrite standard powders were reconstituted with 1.0 
ml of Assay buffer by mixing and vortexing thoroughly and were stored at 4°C.  Griess 
reagents R1 (Sulphanilic Acid) and R2 (N-alpha-naphthyl-ethylenediamine) were stored 
at 4°C for further use. 
Nitrite produced (NO2) in water after DBD plasma treatment was measured as an 
indicator of the amount of nitric oxide induced to samples after plasma treatment. For this 
purpose, nitrite standard curve was prepared during the experiment. 0.1 ml of 
reconstituted nitrite standard was added to 0.9 ml of assay buffer and vortexed. Each 0, 5, 
10, 15, 20, 25, 30 and 35 µl of this nitrite standard were added to wells of a 96 well plate 
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and were mixed with 100, 95, 90, 85, 80, 75, 70 and 65 µl of assay buffer respectively. 3 
ml of sterile DI water was plasma treated in a small sterile petridish for 30, 60 and 90 sec 
with 0 sec as control. 100 µl of each plasma treated sample was added to the 96 well 
plate. 50 µl of Griess reagent R1 and 50 µl of Griess reagent R2 were added to each of 
the wells. The well plate was incubated in room temperature for 10 minutes. The 
absorbance was then measured by a fluorescent spectrophotometer (Softmax pro) at 548 
nm (Figure 4-7).  
 
Figure 4-7. Experimental procedure for measurement of nitric oxide in DBD plasma 
treated DI water 
 
4.2.5. SEM 
In order to investigate whether plasma treatment is inducing any damage to the cell 
membrane and induces any changes in cell morphology, E. coli cell culture was prepared 
overnight and diluted to 108 CFU/ml concentrations. The culture was then centrifuged 
and the supernatant was removed. Cells were re-suspended in sterile DI water. Various 
dilutions were prepared. Then 20 µl of each dilution was pipetted on aluminum sample 
holder and treated with DBD plasma for 60 sec and then dried for 30 minutes. For control 
67
  
samples, 20 µl of each dilution where pipetted on the aluminum sample holders and dried 
for 30 minutes. The SEM (make and model) pictures were then taken. 
 
4.3. Results and Discussion 
In order to investigate the effects of DBD plasma treatment on decontamination of 
bacteria in solution, E. coli cells suspensions in sterile DI water were plasma treated. The 
plasma treatment was done in various depths of liquid to assess the bactericidal efficacy 
of plasma treatment and diffusion of antibacterial agents produced by plasma in liquid 
depth. More over the antibacterial efficacy of plasma treated DI water was investigated to 
examine the possibility of using the plasma treated water as an antiseptic liquid. To better 
understand the process which leads to the inactivation of bacterial cells in liquid phase, 
pH and the stable NO metabolite (NO2) concentration in the plasma treated samples were 
measured. Morphological changes of the plasma treated bacterial cells were also 
investigated using SEM to further investigate the influence of plasma treatment on the 
cell membranes. 
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4.3.1. Efficacy of DBD plasma treatment on bacteria in DI water 
 
Figure 4-8. Rapid inactivation of E. coli cells following direct plasma treatment in 
suspensions in the containers with various depths. For 1mm deep container, 7 log 
reductions in bacterial concentration is observed after 30 seconds of plasma treatment. 
Result demonstrated rapid reduction of E. coli cell concentration in suspension, following 
direct plasma treatment in containers with various depths. For 1mm deep container, 7 log 
reductions in bacterial concentration is observed after 30 seconds of plasma treatment. 
Keeping the cross-section area of the containers constant, increasing the depth of the 
solution is reducing the efficacy of plasma treatment. 
Result demonstrated rapid reduction in E. coli cell suspension concentration following 
direct plasma treatment. For 1mm deep container, 7 log reductions in bacterial 
concentration is observed after 30 sec of plasma treatment (Figure 4-8). Keeping the 
cross-section area of the containers constant, increasing the depth of the solution is 
reducing the efficacy of plasma treatment. Increasing the treatment time has a direct 
relation with the efficacy. During this experiment we were trying to simulate the possible 
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treatment of human wounds which may contain a considerable amount of liquid. It can be 
concluded that the reactive species produced by plasma are diffusing in liquid and 
interacting with the bacterial cells. Considering the results and the preliminary 
experiments, we can claim that for a constant volume of liquid the bactericidal efficacy of 
plasma treatment will decrease with increasing the depth and decreasing the cross section 
and. This may suggest that DBD plasma treatment might have more bactericidal efficacy 
if used on superficial wide wounds compared to deep wounds. 
 
 
4.3.2. Bactericidal Efficacy of Plasma Treated DI Water 
 
Figure 4-9. 2 log reductions in E. coli concentration with the original concentration of 
109 was observed after 30 min exposure to 120 sec plasma treated DI water 
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Results demonstrated about 2 log reductions in E. coli cell density with the original 
concentration of 109 after 30 min exposure to 3 ml DI water which was plasma treated for 
120 sec. 
Figure 4-9 represents the results of examining the bactericidal efficacy of plasma treated 
DI water. 2 log reductions in E. coli cell density with the original concentration of 109 
was observed after 30 min exposure to 3 ml of 120 sec plasma treated DI water. 
Considering the previous results in literature we expect to have significantly more log 
reductions with decreasing the starting concentration of bacterial cell suspension. With a 
notably high starting concentration of 109 and only 120 sec of plasma treatment of the 
water, we have 90% reduction in bacterial concentration. This means that plasma treated 
DI water might be a good candidate to be used as an antiseptic agent. More investigations 
should be implemented on this issue. 
4.3.3. pH measurement 
 
Figure 4-10. pH change of the plasma treated DI water in 4 mm deep container. Results 
demonstrated a significant drop of pH after only 30 sec of plasma treatment. * denote 
statistical differences from the untreated group. (P<0.05(t-test)) 
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Figure 4-11. pH change of the plasma treated DI water in containers with various depths 
for 60 sec plasma treatment duration. Results demonstrated a significant drop of pH after 
60 sec of plasma treatment for all the depths. * denote statistical differences from the 
untreated group. (P<0.05(t-test)) 
 Figure 4-10 is representing pH change in the plasma treated DI water. A significant drop 
in pH is observed after only 30 sec of plasma treatment in the 4mm deep container. In 
order to examine whether plasma treatment induces different levels of pH change in 
smaller amount of liquid, DI water was plasma treated for 60 sec in containers with 1, 2, 
3 and 4mm depths and a constant cross section area of 10 mm. Results presented in 
Figure 4-11 demonstrated that all the treated samples reached pH level of ~ 3.9. Results 
demonstrated a significant drop of pH after 60 sec of plasma treatment for all the 
samples. The acidification level is same for all the depths and results show that the pH 
will not go below this level even for the smaller liquid volumes. 
 To investigate the effect of plasma treatment on pH of larger amounts of liquid 3, 15 
and, 50 ml of DI water were plasma treated. Figure 4-12 demonstrated that even for up to 
15 ml of liquid plasma is reducing the pH to the same level (~3.9). Results indicate that 
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for creating the same level of pH reduction in larger volumes of DI water (50 ml) 
prolonged plasma treatment times may be required. The effect of aging of the treated 
liquid on pH following plasma treatment was also invested (Figure 4-13). The 
acidification level demonstrated to be approximately stable over 17 hour monitoring 
period post plasma treatment. The slight reduction in pH could be because of evaporation 
of the plasma treated water during 17 hours of incubation in room temperature. 
Measuring the pH change for plasma treated SBF for 1,2,3,4 and5 min showed no pH 
change. Since this solution is highly buffered significantly longer treatment durations 
might be necessary to have an impact on its pH. 
 
 
Figure 4-12. Plasma treatment induces pH reduction in different volumes of plasma 
treated water. Results demonstrated that for inducing the same pH reduction in a very 
large volume of DI water prolonged treatment times are required   
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Figure 4-13. Aging effect on pH following plasma treatment. The induced acidification 
demonstrated to be approximately stable over 17 hour monitoring period following 
plasma treatment. The slight reduction in pH could be because of partly evaporation of 
the plasma treated water after 17 hours   
 
4.3.4. Griess Assay 
Penetration of DBD Plasma-Generated Nitric Oxide into liquid media 
Following 30 sec, 60 sec, and 90 sec DBD plasma treatment, NO2 amount within DI 
water was measured using Griess assay. Nitrite (NO2) is the stable metabolite of NO 
especially in vitro [75], thus it can be used to measure NO indirectly.  Figure 4-15 
demonstrates the changes in NO2 amount introduced to the sterile DI water with various 
DBD plasma treatment durations. It can be seen that NO2 amount within DI water 
increased with prolonged DBD plasma treatment time. This means that the amount of 
plasma associated NO induced into the media had increased with increasing the treatment 
time.  The NO amount for all DBD plasma treated groups were statistically different than 
the control group (p<0.05). The results demonstrated that the DBD plasma treatment in 
inducing a significant amount of NO into sterile DI water. There were 10-fold, 15-fold, 
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and 20-fold increases in NO2 amount for 30 sec, 60 sec, and 120 sec DBD plasma treated 
DI water compared to control, respectively. The various concentrations of NO were 
introduced into the sterile DI water following various DBD plasma treatment time. 
Results demonstrated that the NO concentration was positively correlated with DBD 
plasma treatment time and with prolonged treatment times, the higher NO concentrations 
were introduced to the plasma treated DI water. These findings are very important 
because NO has been well-known for its antibacterial effects for many years [49]and 
DBD plasma as a system that is able to introduce different concentrations of NO will be 
appreciated as a system for microbial decontamination. 
 
 
Figure 4-14. Standard curve derived using NO donor 
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Figure 4-15. The changes in NO2 concentration within the sterile DI water with various 
DBD plasma treatment times. Results are expressed as mean ± SD concentration (µM) 
(n=4). *, **denote statistical differences from 30 sec, 60 sec NO-plasma treatment 
groups, respectively (p<0.05) 
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4.3.5. Scanning Electron Microscopy (SEM) 
 
Figure 4-16. A) Untreated E. coli after 30 min air drying B) 60 sec plasma treated E. coli 
cells  
 
20 µl of each dilution was pipetted on aluminum sample holder and treated with DBD 
plasma for 60 sec and then dried for 30 minutes. For control samples, 20 µl of each 
dilution where pipetted on the aluminum sample holders and dried for 30 minutes. The 
SEM pictures were then taken. SEM pictures demonstrated slight morphological change 
in bacterial cells following 60 sec of plasma treatment (Figure 4-16). More treatment time 
might be necessary to induce significant visible damage to the cell structures based on 
previous studies [76]. Another factor that might cause less signs of damage in our 
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experiment compared to the previous studies might be that they treated the bacteria after 
drying on surface with no liquid and that way cells may be more susceptible to physical 
damage compared to our practice that plasma treatment is done on cells in suspension.  
4.4.Summary 
The DBD plasma is inactivating E. coli cells in aqueous solutions and the efficacy of the 
treatment is highly dependent on the dosage of plasma and the initial concentration of the 
bacteria. The depth of the plasma treated liquid is also affecting the efficacy of treatment. 
Since plasma treated DI water is also showing bactericidal properties, it can be a 
candidate to be used as an antiseptic liquid. Although the bactericidal efficacy of direct 
plasma treatment is more than the plasma treated DI water. Plasma treatment of DI water 
is acidifying the liquid and induces nitric oxide in the media. These changes in properties 
seem to be stable over a notably long period of time. Nitric oxide production and pH 
reduction (which could be associated with nitric oxide concentration in part), are the two 
of the main agents that could be responsible in chemically effecting the bacterial cells. 
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Chapter Five 
Conclusions and Future Work 
 
In current study the decontamination efficacy of DBD plasma treatment on E. coli and 
MRSA species was investigated in a planktonic phase and in colonies on the surface of 
agarose gel as well as in suspension.  
We demonstrated that DBD plasma has the potential to be used for decontamination of 
antibiotic resistant species. Antibiotic resistance in S. aureus, one of the most common 
musculoskeletal pathogens, is a serious problem. The effect of cold plasma treatment on 
the decontamination of MRSA and E. coli in a planktonic culture and colonies were 
studied. Cold plasma treatment is a bactericidal treatment and is an effective way for 
inactivating E. coli and MRSA strains ATCC BAA-1556, ATCC BAA-1717 and ATCC 
33591 in planktonic phase and in colonies on agar surface.  Longer treatment times are 
needed to observe a uniform distribution of treatment effect on the treated area. For a 
given strain, longer treatment time is needed to completely inactivate bacteria in colonies 
than planktonic phase. With longer treatment times the reactive species like nitric oxide 
diffuse more into the agar radial and also in depth and results show growing in inhibition 
zone with longer treatment times. These results in having sterilized area that is bigger 
than the area of the electrode which corresponds to the directly plasma treated area. This 
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implies that the effect of plasma on the cells should be chemical and not only dependent 
on the physical damage of the cells by bombardment of the cells with charged particles.  
The DBD plasma is inactivating the bacterial cells in all the examined environments and 
the efficacy of the treatment is highly dependent on the dosage of plasma and the initial 
concentration of the bacteria. The depth of the plasma treated liquid is also affecting the 
efficacy of treatment. Plasma treated DI water is also showing bactericidal properties and 
can be a candidate to be used as an antiseptic liquid although the bactericidal efficacy of 
direct plasma treatment is more than the plasma treated DI water. Plasma treatment of DI 
water is acidifying the liquid and induces nitric oxide in the media. These changes in 
properties seem to be stable over a notably long period of time. Nitric oxide production 
and pH reduction (which could be associated with nitric oxide concentration in part), are 
the two of the main agents that could be responsible in chemically effecting the bacterial 
cells. 
Future work In Vitro will involve in investigating the bactericidal efficacy of DBD 
treatment in depth of agarose gel as a model resembling tissue. Also detection and 
measurement of hydrogen peroxide in plasma treated media as another well-known 
bactericidal agent will be important. Moreover, Treatment of bacterial cells in SBF as a 
good model for body fluid can give us more insight on the efficacy of the treatment on 
wound. To better understand how each agent produced in plasma is playing role in 
bacterial inactivation, investigating the effect of each agent separately on the bacterial 
cells would be helpful.  
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